BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29148398)

  • 1. Investigation of Acute Flaccid Paralysis Reported with La Crosse Virus Infection, Ohio, USA, 2008-2014.
    Hennessey MJ; Pastula DM; Machesky K; Fischer M; Lindsey NP; DiOrio M; Staples JE; de Fijter S
    Emerg Infect Dis; 2017 Dec; 23(12):2075-2077. PubMed ID: 29148398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newly recognized focus of La Crosse encephalitis in Tennessee.
    Jones TF; Craig AS; Nasci RS; Patterson LE; Erwin PC; Gerhardt RR; Ussery XT; Schaffner W
    Clin Infect Dis; 1999 Jan; 28(1):93-7. PubMed ID: 10028077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Periodic lateralized epileptiform discharges in La Crosse encephalitis, a worrisome subgroup: clinical presentation, electroencephalogram (EEG) patterns, and long-term neurologic outcome.
    de los Reyes EC; McJunkin JE; Glauser TA; Tomsho M; O'Neal J
    J Child Neurol; 2008 Feb; 23(2):167-72. PubMed ID: 18160548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age influences susceptibility of brain capillary endothelial cells to La Crosse virus infection and cell death.
    Basu R; Nair V; Winkler CW; Woods TA; Fraser IDC; Peterson KE
    J Neuroinflammation; 2021 Jun; 18(1):125. PubMed ID: 34082753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. La Crosse encephalitis in children.
    McJunkin JE; de los Reyes EC; Irazuzta JE; Caceres MJ; Khan RR; Minnich LL; Fu KD; Lovett GD; Tsai T; Thompson A
    N Engl J Med; 2001 Mar; 344(11):801-7. PubMed ID: 11248155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe La Crosse encephalitis with significant neurologic sequelae.
    Balkhy HH; Schreiber JR
    Pediatr Infect Dis J; 2000 Jan; 19(1):77-80. PubMed ID: 10643856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroinvasive arboviral disease in the United States: 2003 to 2012.
    Gaensbauer JT; Lindsey NP; Messacar K; Staples JE; Fischer M
    Pediatrics; 2014 Sep; 134(3):e642-50. PubMed ID: 25113294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological survey and active surveillance for La Crosse virus infections among children in Tennessee.
    Jones TF; Erwin PC; Craig AS; Baker P; Touhey KE; Patterson LE; Schaffner W
    Clin Infect Dis; 2000 Nov; 31(5):1284-7. PubMed ID: 11073765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double Crossed: A Case of La Crosse Encephalitis.
    Ding A; Shen B; Elliott S; Joshi K; Coghlin D; McLaughlin S
    R I Med J (2013); 2020 Apr; 103(3):59-62. PubMed ID: 32236166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Throw out the Map: Neuropathogenesis of the Globally Expanding California Serogroup of Orthobunyaviruses.
    Evans AB; Peterson KE
    Viruses; 2019 Aug; 11(9):. PubMed ID: 31470541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. La crosse virus encephalitis preceding neurosarcoidosis diagnosed by brain biopsy.
    Kobayashi D; Rouster-Stevens K; Harper A
    Pediatrics; 2011 Apr; 127(4):e1091-6. PubMed ID: 21402636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. La Crosse Encephalitis: An Adult Case Series.
    Teleron AL; Rose BK; Williams DM; Kemper SE; McJunkin JE
    Am J Med; 2016 Aug; 129(8):881-4. PubMed ID: 27086496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. La Crosse encephalitis in Eastern Tennessee: clinical, environmental, and entomological characteristics from a blinded cohort study.
    Erwin PC; Jones TF; Gerhardt RR; Halford SK; Smith AB; Patterson LE; Gottfried KL; Burkhalter KL; Nasci RS; Schaffner W
    Am J Epidemiol; 2002 Jun; 155(11):1060-5. PubMed ID: 12034585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. La Crosse Virus Disease in the United States, 2003-2019.
    Vahey GM; Lindsey NP; Staples JE; Hills SL
    Am J Trop Med Hyg; 2021 Jul; 105(3):807-812. PubMed ID: 34280142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative sequence analyses of La Crosse virus strain isolated from patient with fatal encephalitis, Tennessee, USA.
    Lambert AJ; Fryxell RT; Freyman K; Ulloa A; Velez JO; Paulsen D; Lanciotti RS; Moncayo A
    Emerg Infect Dis; 2015 May; 21(5):833-6. PubMed ID: 25898269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. La Crosse Encephalitis: A Persistent Arboviral Threat in North Carolina.
    Byrd BD
    N C Med J; 2016; 77(5):330-3. PubMed ID: 27621342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of La Crosse Virus Emergence, Appalachia Region, United States.
    Bewick S; Agusto F; Calabrese JM; Muturi EJ; Fagan WF
    Emerg Infect Dis; 2016 Nov; 22(11):1921-1929. PubMed ID: 27767009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An adolescent with flaccid monoplegia.
    Knapp JF; Love J; Singer JI
    Pediatr Emerg Care; 2002 Jun; 18(3):209-11. PubMed ID: 12066011
    [No Abstract]   [Full Text] [Related]  

  • 19. La Crosse virus infectivity, pathogenesis, and immunogenicity in mice and monkeys.
    Bennett RS; Cress CM; Ward JM; Firestone CY; Murphy BR; Whitehead SS
    Virol J; 2008 Feb; 5():25. PubMed ID: 18267012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The spatial epidemiology and clinical features of reported cases of La Crosse virus infection in West Virginia from 2003 to 2007.
    Haddow AD; Bixler D; Odoi A
    BMC Infect Dis; 2011 Jan; 11():29. PubMed ID: 21269495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.